Soleus Capital Management, L.P. C4 Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

$1.18 Billion
Q3 2024

A detailed history of Soleus Capital Management, L.P. transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 6,603,996 shares of CCCC stock, worth $26.5 Million. This represents 3.2% of its overall portfolio holdings.

Number of Shares

6,603,996

Previous 4,051,996 62.98%

Holding current value

$26.5 Million

Previous $18.7 Million 101.08%

% of portfolio

3.2%

Previous 1.9%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.43 - $7.38 $11.3 Million - $18.8 Million	2,552,000 Added 62.98%	6,603,996 $37.6 Million
Q2 2024 Aug 14, 2024	BUY	$4.05 - $8.1 $6.45 Million - $12.9 Million	1,593,000 Added 64.78%	4,051,996 $18.7 Million
Q1 2024 May 15, 2024	BUY	$5.3 - $11.0 $3.3 Million - $6.85 Million	623,000 Added 33.93%	2,458,996 $20.1 Million
Q4 2023 Feb 14, 2024	SELL	$1.18 - $6.03 $1.01 Million - $5.16 Million	-856,024 Reduced 31.8%	1,835,996 $10.4 Million
Q2 2023 Aug 14, 2023	BUY	$2.75 - $3.77 $838,750 - $1.15 Million	305,000 Added 12.78%	2,692,020 $7.4 Million
Q1 2023 May 15, 2023	SELL	$3.1 - $9.02 $166,851 - $485,483	-53,823 Reduced 2.21%	2,387,020 $7.5 Million
Q4 2022 Feb 14, 2023	BUY	$5.42 - $10.24 $5.42 Million - $10.2 Million	999,330 Added 69.33%	2,440,843 $14.4 Million
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $9.31 Million - $14.8 Million	1,158,873 Added 410.02%	1,441,513 $12.6 Million
Q2 2022 Aug 15, 2022	BUY	$5.06 - $26.46 $586,474 - $3.07 Million	115,904 Added 69.51%	282,640 $2.13 Million
Q1 2022 May 16, 2022	SELL	$19.99 - $33.23 $7.88 Million - $13.1 Million	-394,386 Reduced 70.29%	166,736 $4.05 Million
Q4 2021 Feb 14, 2022	SELL	$29.39 - $46.86 $5.57 Million - $8.88 Million	-189,511 Reduced 25.25%	561,122 $18.1 Million
Q3 2021 Nov 15, 2021	SELL	$35.91 - $50.5 $4.31 Million - $6.07 Million	-120,125 Reduced 13.8%	750,633 $33.5 Million
Q2 2021 Aug 16, 2021	BUY	$30.39 - $42.18 $12.4 Million - $17.2 Million	406,690 Added 87.64%	870,758 $32.9 Million
Q1 2021 May 17, 2021	BUY	$31.96 - $46.5 $6.25 Million - $9.09 Million	195,520 Added 72.81%	464,068 $17.2 Million
Q4 2020 Feb 16, 2021	BUY	$22.8 - $37.05 $6.12 Million - $9.95 Million	268,548 New	268,548 $8.9 Million

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $196M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account

Soleus Capital Management, L.P. C4 Therapeutics, Inc. Transaction History